| (+)-JQ-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| (+)-JQ-1-aldehyde |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.07% |
| (+)-JQ1 PA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.16% |
| (1s,4s)-Menin-MLL inhibitor-23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (2R,3R)-GSK973 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (2S,3R)-LP99 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.4% |
| (E/Z)-ZL0420 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (R)-(-)-JQ1 Enantiomer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| (R)-BAY1238097 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.07% |
| (R)-I-BET762 carboxylic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.50% |
| (R)-INCB054329 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.94% |
| (R)-JQ-1 carboxylic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.24% |
| (R)-Ziftomenib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Rac)-BAY1238097 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| (Rac)-CPI-203 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Rac)-EBET-1055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.17% |
| (S)-BI 2536 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (S)-GNE-987 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (S)-GSK852 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.07% |
| (S)-JQ-35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| (S)-JQ-35-Boc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (S)-ML399 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (S,R)-CFT8634 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Z)-JQ1-TCO |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.12% |
| (±)-JQ1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3-Methylcarbostyril |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4-Chloro-N-methylpicolinamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| 4-Pentynoyl-Coenzyme A TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5-Ph-IAA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| 6-O-Isobutyrylbritannilactone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.34% |
| 653-47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 653-47 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.42% |
| 666-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| A-366 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.13% |
| A-485 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| A-485 (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| A-582941 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| A-582941 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.78% |
| A1874 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| AB3067 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AB3145 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ABBV-744 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Ad-JQ1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AF9/ENL-DOT1L PPI-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Alobresib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| AMPTX-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.00% |
| Amredobresib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.97% |
| AMX-883 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AR/BET ligand-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AR/BRD4 RIPTAC-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.65% |
| AR/BRD4 RIPTAC-1 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AR420626 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.40% |
| Artepillin C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.07% |
| ARV-771 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| ARV-825 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.21% |
| AT6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| ATAD2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATF3 inducer 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.61% |
| ATF3-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.30% |
| ATF4 agonist-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATF4-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.24% |
| AU-15330 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| AZ13824374 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.22% |
| AZD5153 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.20% |
| AZD5153 6-Hydroxy-2-naphthoic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.51% |
| Balomenib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| BAY-155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BAY-299 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| BAY-299 (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BAY-850 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.93% |
| BAY1238097 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.02% |
| BAZ1A-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| BAZ2-ICR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| BBC0403 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.78% |
| BC13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BD-9136 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.81% |
| BET BD2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET BD2-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET bromodomain inhibitor 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| BET bromodomain inhibitor 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET bromodomain inhibitor 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.0% |
| BET bromodomain inhibitor 4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| BET bromodomain-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.49% |
| BET-BAY 002 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| BET-BAY 002 (S enantiomer) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.87% |
| BET-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| BET-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BET-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BETd-246 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.34% |
| BETd-260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| BETi-211 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BI 2536 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| BI 2536 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BI 7271 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BI-7273 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| BI-7273 acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BI-9564 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.96% |
| Bi-magnolignan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BI01826025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BiBET |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Biotinylated-JQ1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.33% |
| Birabresib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| BMS-986158 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| BRD-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD-SF2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD2 BD1 ligand-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD3 ligand-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD3/BRD4-L ligand-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 D1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 D1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 D1-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 degrader AT1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.68% |
| BRD4 degrader-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| BRD4 degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 degrader-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.41% |
| BRD4 degrader-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 degrader-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 degrader-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| BRD4 Inhibitor-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.34% |
| BRD4 Inhibitor-13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.08% |
| BRD4 Inhibitor-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.24% |
| BRD4 Inhibitor-23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.27% |
| BRD4 Inhibitor-25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| BRD4 Inhibitor-31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-33 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.84% |
| BRD4 Inhibitor-36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-38 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-39 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 Inhibitor-40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 ligand 13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 ligand 14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 ligand 15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 ligand 6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4 ligand 6 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| BRD4 ligand 8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-BD1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-BD1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-BD1/2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-BD1/2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-BD1/2-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| BRD4-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.0% |
| BRD4-IN-41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-IN-42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4/AKT-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4/CK2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.21% |
| BRD4/FKBP12 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4/FKBP12 degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4/NAMPT-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| BRD7-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| BRD7-IN-1 free base |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD7-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.29% |
| BRD7-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD9 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD9 Degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD9 Degrader-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD9 Degrader-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD9 ligand-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD9 ligand-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD9 ligand-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD9 ligand-13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD9 ligand-14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD9 ligand-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRDT-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRDT-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRM/BRG1 ligand 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRM/BRG1 ligand 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bromodomain IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bromodomain IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bromodomain inhibitor-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bromodomain inhibitor-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bromodomain inhibitor-12 (edisylate) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bromodomain inhibitor-13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bromodomain inhibitor-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| Bromodomain inhibitor-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bromosporine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| BRPF1B/TRIM24-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BT-O2C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.31% |
| BT-PROTAC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BTR2004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| BTR2038 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BY27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C646 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Cath-L-dBET1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CAU |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP-IN-1 acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP/EP300 bromodomain receptor-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP/EP300 ligand-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP/p300 ligand 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP/p300 ligand 4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP/p300 ligand 5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP/p300-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.71% |
| CBP/p300-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| CBP/p300-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP/p300-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP/p300-IN-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.03% |
| CBP/p300-IN-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP/p300-IN-22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP/p300-IN-24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBP/p300-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.01% |
| CBP/p300-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.03% |
| CBP/p300/BRD4 ligand-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| cBu-Cit-GAL-02-221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CCW 28-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.38% |
| CD161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| CD235 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDC14A/B-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDD-1128 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDD-1132 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDD-1147 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDD-1154 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDD-1349 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDD-1498 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDK4/6/BRD4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CeMMEC1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.94% |
| CeMMEC2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CF53 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| CFT-1297 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.06% |
| CFT-2718 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| CFT-743 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CFT8634 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.10% |
| cis-MZ 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.72% |
| cis-MZ 1 hydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| cis-Revumenib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.92% |
| cis-SIM1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| cis-VZ185 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CK2-TN03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| CN427 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CPI-0610 carboxylic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CPI-203 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| CPI-203-PEG1-C3-O-COOH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CPI-637 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| CPI703 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CREB-IN-1 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CREBBP-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CREBBP-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CTK7A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CW 008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.15% |
| CW-3308 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.43% |
| CZL-046 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CZL-077 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CZL-149 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| D-Moses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DAO-dBET1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| dBAZ2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| dBAZ2B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| dBET1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.96% |
| dBET23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.83% |
| dBET57 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| dBET6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| DBr-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.87% |
| dBRD 9-A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.07% |
| dBRD4-BD1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| dBRD9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| dBRD9 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| DC-BPi-03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| DC-CPin7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DC-CPin711 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.09% |
| DC-peptoid-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| dCBP-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.37% |
| DDO-8926 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DDO-8958 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Desmethyl-QCA276 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.16% |
| Desmethyl-QCA276-C3-alkyne |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| dHTC3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DLG-41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.06% |
| DLG-41nc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DN02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.68% |
| DP-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.06% |
| dTRIM24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| DW34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DW71177 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.70% |
| E-7386 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.11% |
| EBET-1055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EBET-1593 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EBET-590 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EED-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| eIF3e-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Eleven-Nineteen-Leukemia Protein IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Eleven-Nineteen-Leukemia Protein IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Eleven-Nineteen-Leukemia Protein IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Eleven-Nineteen-Leukemia Protein IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Emilumenib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.22% |
| EML 425 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| EML631 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN884 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enzomenib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Enzomenib enantiomer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.01% |
| EP300/CBP ligand 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EP300/CBP-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EP300/CBP-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ET-JQ1-OH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FHD-609 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.95% |
| FKBP12 PROTAC dTAG-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.47% |
| FL-411 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.05% |
| FLT3/JAK2/BRD4 ligand-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FT001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| FWG-33B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GAL-02-221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Gal-ARV-771 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GNE-049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| GNE-207 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| GNE-272 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| GNE-375 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| GNE-781 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.51% |
| GNE-781-COOH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GNE-886 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| GNE-987 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| GNE-987 GSH linker-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.48% |
| GS-626510 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| GSK 4027 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.22% |
| GSK 525768A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| GSK-340 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK-5959 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.73% |
| GSK023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK046 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| GSK097 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK1324726A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| GSK217 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK232 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK2801 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.69% |
| GSK4028 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.06% |
| GSK620 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| GSK6853 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| GSK737 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| GSK761 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.64% |
| GSK778 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.14% |
| GSK778 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK785 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK789 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK852 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.62% |
| GSK8573 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| GSK8573 (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK8814 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| GSK9311 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.33% |
| GSK9311 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK973 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| GW 841819X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GXF-111 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GXH-II-052 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC/JAK/BRD4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3/BRD4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8/BRPF1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hedgehog IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hexamethylene bisacetamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.56% |
| HJB97 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.12% |
| HL403 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HL435 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HLDA-221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.24% |
| HR-19011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.64% |
| HRG038 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hsp70TAC BRD4 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hyp-dBET1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| I-BET151 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.47% |
| I-BET151 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| I-BET282 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.90% |
| I-BET282E |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| I-BET432 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| I-BET567 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.49% |
| I-BET762 carboxylic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.55% |
| I-BET787 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| I-BRD9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| I-CBP112 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.43% |
| I-CBP112 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IACS-9571 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IACS-9571 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.27% |
| IACS-9571 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IBG1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| IBG3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.53% |
| iBRD4-BD1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.77% |
| iBRD4-BD1 diTFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| Icovamenib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.96% |
| iHAC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IL-6/RIPK3-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| INCB-057643 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.34% |
| INCB054329 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.00% |
| INCB054329 Racemate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Inobrodib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| iP300w |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ischemin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| Ischemin sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.32% |
| Isoxazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| JQ-1 (carboxylic acid)-amine-PEG8-cyanogen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JQ-1 (carboxylic acid)-NH-C2-NH-AMPRO-222 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JQ-1 carboxylic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.69% |
| JQ-1-Azidopropylamine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.5700% |
| JQ1-FITC TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JQ1-JX5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JQ1-S(GlcNAc)Cq |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JQ1-TCO |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| JV8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JWZ-7-7-Neg1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JY-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| K2-B4-3e |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| K2-B4-5e |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KB-0118 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KB02-JQ1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.10% |
| KB528 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KBD-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KG-501 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| KMI169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.00% |
| KMT9-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KMT9-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KWZL-7f15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L-Moses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.55% |
| L-Moses dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| L134 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.37% |
| L1BC8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.20% |
| LCI40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LGF308 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lin28-let-7 antagonist 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.43% |
| LO-3-61 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LP99 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.18% |
| LS-170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LT052 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| M-1211 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.29% |
| M-525 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| M-808 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.72% |
| M‑89 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.14% |
| MACTIDE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MACTIDE-V |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menin–KMT2A-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menin-MLL inhibitor 19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.07% |
| Menin-MLL inhibitor 20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.81% |
| Menin-MLL inhibitor 29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menin-MLL inhibitor 31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menin-MLL inhibitor 33 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menin-MLL inhibitor 34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menin-MLL inhibitor 4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menin-MLL inhibitor MI-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.41% |
| Menin-MLL inhibitor MI-2 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menin-MLL inhibitor-22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Menin-MLL inhibitor-25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menin-MLL-IN-32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menin-MLL-IN-35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menin-MLL-IN-36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menin-MLL-IN-37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MG 149 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| MI-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MI-136 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.04% |
| MI-1481 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MI-2-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| MI-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| MI-3454 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.03% |
| MI-389 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.34% |
| MI-463 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| MI-503 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| MI-538 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.23% |
| MI-nc dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| MIV-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mivebresib-alkyne |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MJ-26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ML 2-14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.43% |
| ML399 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MM-02-08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MMH1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| MMH1-NR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.36% |
| MMH2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.95% |
| MMH2-NR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.72% |
| Molibresib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Molibresib besylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.04% |
| MR2-cy5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MrTAC-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MS108 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MS31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MS31 trihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| MS402 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.36% |
| MS41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.97% |
| MS417 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| MS436 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| MS479 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MS645 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| MS83 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MS8535 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MT1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.69% |
| mUNO |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.50% |
| MZ 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| MZ 1 (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MZP-54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.03% |
| MZP-55 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| N6-Cyclohexyladenosine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| Naphthol AS-E |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Naphthol AS-MX phosphate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.50% |
| NB512 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NC-III-49-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NEO2734 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.63% |
| NEP108 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NEP162 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NHWD-870 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.36% |
| NI-42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| NI-57 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.42% |
| NICE-01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| NSC 228155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| NVS MLLT-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| NVS-BET-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NVS-CECR2-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| OARV-771 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.77% |
| ODM-207 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| OF-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.93% |
| Olinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| OXFBD02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| OXFBD03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| OXFBD04 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.99% |
| P300 bromodomain-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| pan-BET/BD2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/BRD4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/BRD4-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/BRD4-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PBRM1-BD2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PBRM1-BD2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
≥99.0% |
| PBRM1-BD2-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PBRM1-BD2-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PBRM1-BD2-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| PBRM1-BD2-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PBRM1-BD2-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PBRM1-BD2-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.05% |
| PCAF/GCN5 ligand 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PCC0105005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PCIP-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pelabresib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Penipanoid C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PFI-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| PFI-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.03% |
| PFI-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| PFI-6-COOH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phoenixin-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| Phoenixin-20 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PI3K/Akt/CREB activator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.64% |
| PI3K/AKT/ERK/CREB activator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PI3Kα-IN-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PI3Kδ/BET-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PKI 14-22 amide,myristoylated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.96% |
| PKI 14-22 amide,myristoylated TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| PLK1-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PLK1/BRD4-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.92% |
| PLK1/BRD4-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.55% |
| PLK1/BRD4-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.80% |
| PLX-3618 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| PLX-4104 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PLX51107 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| PNZ5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.61% |
| Polygalasaponin XXXII |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pomalidomide-C5-Dovitinib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Progranulin modulator-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC AR/BET protein degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BET Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.41% |
| PROTAC BET Degrader-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.39% |
| PROTAC BET Degrader-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.10% |
| PROTAC BET Degrader-13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BET Degrader-14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BET Degrader-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BET Degrader-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BET Degrader-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BET Degrader-18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BET Degrader-19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BET degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.21% |
| PROTAC BET degrader-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.11% |
| PROTAC BET-binding moiety 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| PROTAC BRD2 BD1 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD2/BRD4 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD3 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD3/BRD4-L degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader linker conjugate-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.23% |
| PROTAC BRD4 Degrader linker conjugate-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| PROTAC BRD4 Degrader linker conjugate-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.54% |
| PROTAC BRD4 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.31% |
| PROTAC BRD4 Degrader-14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.30% |
| PROTAC BRD4 Degrader-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-33 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-38 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-39 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-43 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-5-CO-PEG3-N3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.73% |
| PROTAC BRD4 Degrader-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| PROTAC BRD4 ligand-1-NH-PEG-phenol-PEG-COOtBu |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 ligand-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 ligand-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4-binding moiety 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.10% |
| PROTAC BRD4-binding moiety 1 (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD4-DCAF1 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD9 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.16% |
| PROTAC BRD9 Degrader-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD9 Degrader-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD9 Degrader-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.06% |
| PROTAC BRD9 Degrader-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD9 Degrader-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.19% |
| PROTAC BRD9 Degrader-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.24% |
| PROTAC BRD9 Degrader-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD9 Degrader-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BRD9-binding moiety 5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC CBP/P300 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| PROTAC CBP/P300 Degrader-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.55% |
| PROTAC CBP/p300/BRD4 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC FLT3/JAK2/BRD4 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC MLLT1 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC p300 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC RNF4 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| QA-68 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| QCA570 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.30% |
| RAJQ14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Repibresib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Revumenib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| RMM23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ROCK2-IN-13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rolipram |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RVX-297 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.00% |
| RWT9996 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RX-37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SB-284851-BT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SB-699551 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| SDR-04 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SDU-071 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.75% |
| SF2523 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.34% |
| SGC-BRDVIII-NC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SGC-CBP30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| SGC-iMLLT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.33% |
| SIM1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.47% |
| SJ1461 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SJ44236 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SJ46420 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SJ46421 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SJ995973 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.88% |
| SJH1-51B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SMARCA2/4-ligand-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Snail IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.27% |
| SNIPER(BRD)-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| SR-0813 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| SR-1114 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.22% |
| SRG-II-19F |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SRX3177 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.33% |
| SRX3212 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SYC-2863 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TAF1 ligand 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TAT-PiET |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TAT-PiET-PROTAC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| TC AC 28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TD-428 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.81% |
| TDI-11055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.18% |
| TEC 4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TK-285 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TKP-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TMU454 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TMX1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.57% |
| TP-238 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TP-238 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.80% |
| TP-472 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.54% |
| TP-472N |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TPOP146 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.94% |
| trans-BAY-850 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.30% |
| TRIM24/BRPF1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.74% |
| TrimTAC1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trotabresib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| TW9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UMB-136 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UMB-32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.11% |
| UMB298 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.28% |
| UNC 669 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| UNC-1679 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UNC10142 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| UNC1021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| UNC1079 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| UNC6212 (Kme2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UNC6349 (Ket2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UNC6864 (Kei) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UNC926 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| UNC926 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UNO peptide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VinSpinIn |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VTP50469 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| VTP50469 fumarate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| VTP50469 mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VZ185 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| WNY0824 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| WWL0245 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XD14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.02% |
| XDM-CBP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XL-126 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XMD8-92 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.48% |
| XP-524 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| XQ2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XS018661 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XX-650-23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| XY-06-007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.9% |
| XY153 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XY221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XYD129 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XYD190 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XYD198 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XYD224 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XYD270 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Y02224 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Y06036 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.57% |
| Y06137 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Y08060 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Y08175 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Y08262 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Y08284 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Y16524 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Y16526 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| YM458 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.16% |
| YT117R |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| YTH-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.66% |
| Z118332870 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Zavabresib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| Zefamenib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| ZEN-2759 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.51% |
| ZEN-3219 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| ZEN-3411 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZEN-3694 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| ZEN-3862 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.86% |
| Ziftomenib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.43% |
| Ziftomenib-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZL0420 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| ZL0454 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| ZL0516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZL0580 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.42% |
| ZL0590 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| ZLD2218 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.24% |
| ZnPc-O3-JQ1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZX079 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZXH-3-26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| ZZ7-23-022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| β-NF-JQ1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.05% |
| β-Patchoulene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Naringenin triacetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| Rolipram |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Curcumin-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.78% |
| Curcumin-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Curcumin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.63% |
| Murine Thrombin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Luteolin 7-sulfate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
90.0% |
| Myricetin 3-O-galactoside |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.27% |
| Lanthanum(Ⅲ) chloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| Anacardic Acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.49% |
| Canine Thrombin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mivebresib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.29% |
| Apabetalone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.34% |